INmune Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. 

CEO
Raymond J. Tesi
CEORaymond J. Tesi
Employees
10
Employees10
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2015
Founded2015
Employees
10
Employees10

INMB Key Statistics

Market cap
209.23M
Market cap209.23M
Price-Earnings ratio
-7.69
Price-Earnings ratio-7.69
Dividend yield
Dividend yield
Average volume
70.92K
Average volume70.92K
High today
$12.05
High today$12.05
Low today
$11.28
Low today$11.28
Open price
$11.81
Open price$11.81
Volume
96.50K
Volume96.50K
52 Week high
$14.74
52 Week high$14.74
52 Week low
$5.87
52 Week low$5.87

INMB News

Simply Wall St 6d
Individual investors invested in INmune Bio, Inc. up 10% last week, insiders too were rewarded - Simply Wall St

Key Insights Significant control over INmune Bio by individual investors implies that the general public has more power to influence management and governance-...

Individual investors invested in INmune Bio, Inc. up 10% last week, insiders too were rewarded - Simply Wall St
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.